Avian influenza A (H5N1) virus poses an important pandemic threat.A study by the Congressional Budget Office estimates that theconsequences of a severe pandemic could, in the United States,include 200 million people infected, 90 million clinically ill,and 2 million dead.1 The study estimates that 30 percent ofall workers would become ill and 2.5 percent would die, with30 percent of workers missing a mean of three weeks of work resulting in a decrease in the gross domestic productof 5 percent. Furthermore, 18 million to 45 million people wouldrequire outpatient care, and economic costs . . . [Full Text of this Article]
Source Information
From the Mayo Vaccine Research Group, the Program in Translational Immunovirology and Biodefense, and the Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn.
Bartlett, J. G.
(2006). Planning for Avian Influenza. ANN INTERN MED
145: 141-144
[Abstract][Full Text]
Johansson, B. E., Brett, I. C., Focosi, D., Poland, G. A.
(2006). An inactivated subvirion influenza A (H5N1) vaccine.. NEJM
354: 2724-2725
[Full Text]
(2006). An Inactivated H5N1 Influenza Vaccine -- Good News, Bad News. JWatch General
2006: 5-5
[Full Text]
(2006). An Inactivated H5N1 Influenza Vaccine -- Good News, Bad News. JWatch Infect. Diseases
2006: 2-2
[Full Text]